
DARPA Awards $11.3M to UC San Diego for Engineered Red Blood Cells
UC San Diego has secured an $11.3 million contract from DARPA to engineer 'smart' red blood cells that temporarily boost oxygen delivery and physical endurance. The three-year project, led by Dr. Alejandro Chavez, uses gene editing to create cells that respond to exertion, with potential future applications in treating cancer and vascular diseases.